Woodline Partners LP - Sep 30, 2025 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: ALGS
Shares outstanding: 5.38M shares
Disclosed Ownership: 468K shares
Ownership: 8.7%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 04:15 PM
Date of event: Sep 30, 2025
Previous filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	8.7%	468K	468K	0	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer